Search Results - rekha+patel

1 Results Sort By:
Luteolin for treatment of neuromuscular movement disorder dystonia 16 (DYT16)
Reference #: 01544 The University of South Carolina is offering licensing opportunities for Luteolin for treatment of neuromuscular movement disorder dystonia 16 (DYT16) Background: DYT16 is a rare movement disorder, so the number of patients worldwide is small. However, Alzheimer's disease, Down syndrome are very prevalent and large numbers...
Published: 6/13/2024   |   Inventor(s): Rekha Patel
Keywords(s): anti-inflammatory pharma, dystonia, DYT16, inflammation, movement disorder, PACT, PKR
Category(s): Biomedical and Life Sciences, Health Sciences